Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-08-28

Clinical Trial Update: A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer [NA]

View source ↗

Summary

This document provides an update on a clinical trial investigating ultra-hypofractionation for unfavourable intermediate and high-risk prostate cancer, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erasmus Medical Center | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING